Cargando…
Modified multiple marker aneuploidy screening as a primary screening test for preeclampsia
BACKGROUND: Abnormal levels of maternal biochemical markers used in multiple marker aneuploidy screening have been associated with adverse pregnancy outcomes. This study aims to assess if a combination of maternal characteristics and biochemical markers in the first and second trimesters can be used...
Autores principales: | Huang, Tianhua, Bedford, H. Melanie, Rashid, Shamim, Rasasakaram, Evasha, Priston, Megan, Mak-Tam, Ellen, Gibbons, Clare, Meschino, Wendy S., Cuckle, Howard, Mei-Dan, Elad |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8903171/ https://www.ncbi.nlm.nih.gov/pubmed/35260099 http://dx.doi.org/10.1186/s12884-022-04514-4 |
Ejemplares similares
-
Prenatal screening for preeclampsia: the roles of placental growth factor and pregnancy–associated plasma protein A in the first trimester and placental growth factor and soluble fms-like tyrosine kinase 1–placental growth factor ratio in the early second trimester
por: Huang, Tianhua, et al.
Publicado: (2023) -
Prenatal screening for trisomy 21: a comparative performance and cost analysis of different screening strategies
por: Huang, Tianhua, et al.
Publicado: (2020) -
Late pregnancy screening for preeclampsia with a urinary point-of-care test for misfolded proteins
por: Li, Xing-Min, et al.
Publicado: (2020) -
Prenatal Screening Using Maternal Markers
por: Cuckle, Howard
Publicado: (2014) -
First Trimester Aneuploidy Screening Program for Preeclampsia Prediction in a Portuguese Obstetric Population
por: Teixeira, Cláudia, et al.
Publicado: (2014)